<DOC>
	<DOCNO>NCT00291096</DOCNO>
	<brief_summary>The overall goal project develop integrative system breast cancer risk assessment base epidemiologic biologic risk variable , well develop refine risk biomarkers may useful predict monitor response prevention intervention .</brief_summary>
	<brief_title>Protocol Women Increased Risk Developing Breast Cancer</brief_title>
	<detailed_description>1 . To correlate establish risk biomarkers cytomorphology obtain random periareolar fine needle aspiration ( RPFNA ) , mammographic breast density , serum bioavailable estradiol IGF-1/IGFBP-3 5-10 year Gail risk estimate . Where available , appropriate safe guard maintain status breast cancer susceptibility gene may include . 2 . To determine relative predictive value establish risk biomarkers development DCIS and/or invasive cancer . 3 . To evaluate potential new breast tissue-based biomarkers include Ki-67 , PCNA , ER , COX-2 , aromatase , methylation key tumor suppressor gene ( i.e. , RAR , p16 , etc ) , proteomic pattern RPFNA nipple aspirate fluid ( NAF ) , well NAF hormone level , correlate risk biomarkers list 1 . 4 . To determine prevalence polymorphisms panel gene important hormone xenobiotic metabolism well DNA repair correlate polymorphism establish risk biomarkers list 1 , well development DCIS invasive cancer . 5 . To maintain contact initially identify cohort high risk woman , acquire demographic data , biologic specimen data follow prospectively development .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>woman least 2 time normal risk develop breast cancer age 3065 ( within 10 year youngest age diagnosis first degree relative ) great six month ingestion antihormonal therapy great 1 year pregnancy , lactation , chemotherapy willing mammogram within six month prior RPFNA willing discontinue NSAIDS herbal supplement willing blood drawn metastatic malignancy kind breast implant tram flap reconstruction radiation breast woman current mammogram clinical breast exam suspicious cancer</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>breast atypia</keyword>
	<keyword>fine needle aspiration</keyword>
	<keyword>high risk breast cancer</keyword>
	<keyword>breast epithelial hyperplasia</keyword>
</DOC>